FDA OKs Updated Moderna and Pfizer-BioNTech COVID-19 Vaccines
The FDA has approved and authorized updated Moderna and Pfizer-BioNTech COVID-19 vaccines for the 2024-2025 season, designed to target current variants.
Tag: BioNTech
FDA OKs Updated Moderna and Pfizer-BioNTech COVID-19 Vaccines
The FDA has approved and authorized updated Moderna and Pfizer-BioNTech COVID-19 vaccines for the 2024-2025 season, designed to target current variants.
Read More
Pfizer and BioNTech Report Mixed Results in Phase 3 Flu-COVID Vaccine Trial
The vaccine candidate showed strong responses against influenza A and COVID-19 but did not meet its goal for influenza B.
Read More
Pfizer and BioNTech Get Positive EU Opinion for Updated COVID-19 Vaccine
The companies also filed an application with the FDA requesting approval of their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine for individuals 6 months of age and older.
Read More